Sugano v. Goeddel II
X. Interference Practice
J. Riding to the End of the Line
3. Koninklijke Eviscerated?
Goeddel v. Sugano
Goeddel was a consolidated appeal from decisions of the BPAI in two different interferences (“the ‘334 interference” and “the ‘337 interference”).
During the administrative phase of the ‘334 interference, Goeddel had filed eight substantive motions, including (1) a motion for a judgment that Sugano’s claims involved in that interference are unpatentable for failure to comply with the written description requirement of 35 USC 112 ¶ 1—which, of course, was a so-called “threshold motion”—and (2) three motions for judgments that Sugano’s claims are unpatentable over prior art, two motions for judgments that Sugano’s claims are unpatentable under 35 USC 101, and one motion for a judgment that Sugano’s claims are unpatentable under the enablement requirement of 35 USC 112 ¶ 1. The two prior art motions were deferred to the second phase of the interference for reasons unspecified in the board’s opinion—but only after the motions had been filed. That is, the parties were not allowed to file oppositions and replies.
During the administrative phase of the ‘337 interference, Goeddel had filed seven substantive motions, including (1) a motion for a judgment that Sugano’s claims involved in that interference are unpatentable for failure to comply with the written description requirement and (2) two motions for judgments that Sugano’s claims are unpatentable over prior art, one motion for a judgment that Sugano’s claims are unpatentable under 35 USC 101, and one motion that Sugano’s claims are unpatentable under the enablement requirement. The two prior art motions were again deferred to the second phase of the interference after the motions had been filed.
In both interferences, the BPAI denied the written description and enablement motions and dismissed the other motions.
In each interference, Sugano had filed four substantive motions: two motions for judgments that Goeddel’s claims are unpatentable over prior art, one motion for a judgment that Goeddel’s claims are unpatentable on the ground of derivation, and a motion for the benefit of the filing date of a Japanese application. In both interferences, the BPAI granted the benefit motion and deferred the other three motions.
What makes the board’s opinion interesting here is its explanation of why it dismissed Goeddel’s prior art motions:
In each interference, we grant Sugano’s motion for benefit of the ‘931 JP application. In each interference, Goeddel’s earliest alleged date of conception is later than the filing date of the ‘931 JP application. Accordingly, Goeddel cannot prevail on priority,
Goeddel has filed a number of motions alleging that some of the involved Sugano claims are unpatentable over prior art…, the natural human chromosome…and or for lack of utility…. We need not decide those motions to complete our determination of priority. We note that:
(1) neither any motion individually, nor the combination of the motions, attack the patentability of all of the involved Sugano claims in either INTERFERENCE. Thus, even if we granted each Goeddel motion attacking patentability, Sugano would have claims directed to mature hFIF and encoding DNA remaining in the interference.
(2) a decision on the patentability of the attacked Sugano claims is not necessary to a determination of priority.
(3) the Sugano claims that Goeddel contends are unpatentable are not part of the substitute Count of either interference and thus deciding the patentability motions could not have the effect of changing the Count,
(4) in interference 105,334, at least as to the prior art challenges, Goeddel has an alternative remedy under 35 USC § 302, and
(5) in interference 105,337, the Board will recommend that the Examiner, upon the resumption of ex parte prosecution, consider the motions filed by Goeddel that attack the patentability of the Sugano claims (as well as any Sugano oppositions and Goeddel replies). Bd.R. 127(c).
In each interference, Sugano motions 1 through 3 have been deferred…. Since judgment will be entered against Goeddel in each interference, we need not and do not decide these deferred motions.
On appeal, the court reversed the BPAI’s decisions granting Sugano’s motions for the benefit of its Japanese priority date and “remanded for appropriate further proceedings.”
I have been informed by counsel that, on remand, the fight is continuing. That is, the board will now have to decide at least some of the motions that it dodged the first time around.
Is this result consistent with Koninklijke Philips Electronics N.V. v. Cardiac Science Operating Co., 590 F.3d 1326, 93 USPQ2d 1227 (Fed. Cir. 2010), discussed in Gholz, The Board Must Decide Every Patentability Motion That is “Fairly Raised and Fully Developed During the Interference”—But Must It Permit Every Authorized Patentability Motion to be “Fully Developed”?, 17 Intellectual Property Today No. 3 (2010) at page 30? Well, the motions that the board didn’t decide the first time around were apparently “fairly raised” (since they were authorized), but they weren’t fully developed (since the board wouldn’t permit them to be).
There is no indication in the court’s opinion that either Sugano or Goeddel complained about the fact that the board didn’t permit full development of all of the motions that it had authorized. However, I suspect that that is because the parties filed their briefs before Koninklijke was decided. Surely others will try to give teeth to what the court said in that opinion!
 See § VI.A., which discusses the Federal Circuit’s reversal of the BPAI’s decisions on that issue.
 Derivation motions are routinely deferred to the second phase of interferences. As to the prior art motions, see footnote 1, supra.
 A poor “alternative remedy” indeed! No discovery and no cross-examination of witnesses!
 What makes this assertion fascinating is that there were no Sugano oppositions and Goeddel replies—because the board had not permitted them to be filed!
 As to this frequent gambit by the APJs, see Gholz, Would You Rather Have Your Opponent’s Patentability Issues Decided Inter Partes or Ex Parte?, 14 Intellectual Property Today No. 10 at page 37 (2007).
 Board opinion pages 50-51.
 ___ F.3d at ___, ___ USPQ2d at ___.
 It is worth noting that the parties’ priority dates go back to 1980!